Integra Lifesciences: Q3 Earnings Insights - Integra Lifesciences (NASDAQ:IART)

Integra Lifesciences IART reported its Q3 earnings results on Wednesday, October 26, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Integra Lifesciences beat estimated earnings by 17.81%, reporting an EPS of $0.86 versus an estimate of $0.73.

Revenue was down $1.67 million from the same period last year.

Last quarter the company beat on EPS by $0.02 which was followed by a 0.42% drop in the share price the next day.

Here's a look at Integra Lifesciences's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	0.80	0.68	0.83	0.72
EPS Actual	0.82	0.74	0.84	0.86
Revenue Estimate	395.27M	362.04M	403.40M	384.58M
Revenue Actual	397.81M	376.64M	405.52M	386.86M

To track all earnings releases for Integra Lifesciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.